S.BIOMEDICS announced encouraging one-year post-transplant results from Phase 1/2a clinical trial evaluating A9-DPC cell ...

Dr. Simrit Parmar, a Northwestern University-trained oncologist and research scientist, launched Cellenkos Inc., in 2016 to accelerate the clinical development of "T regulatory cell" therapies for the ...

A new type of drug, known as an anti-necrotic, could be the first drug ever approved to treat aging itself. The drug, which ...

The instinct to protect and secure a child’s future—especially when it comes to their health—is one of the deepest and most ...

Swiss pharma giant Roche Holding AG (RHHBY) reported sales of CHF 30.9 billion for the first half of 2025, up 4% year over ...

A collaborative study led by Professor Vittoria Raffa at the University of Pisa and Assistant Professor Fabian Raudzus (Department of Clinical Application) has unveiled a novel approach that uses ...

Q2 2025 has demonstrated the pharmaceutical industry’s continued momentum in developing transformative therapies across ...

The Tissue Nanotransfection Market is gaining significant traction in the field of regenerative medicine due to its ...

Emerging research positions TUDCA, a bile acid compound, as a promising neuroprotective agent against Alzheimer’s, ...

New work has shown that what was previously thought of as junk DNA may in fact play an important role in gene regulation.

Transplanting healthy human glial cells into HD mouse brains improved movement, memory, and survival. Even more strikingly, the glia coaxed diseased neurons to behave more like healthy ones, offering ...

An antibody treatment developed at Stanford Medicine successfully prepared patients for stem cell transplants without toxic ...